PHVS
Pharvaris BV
31.70$
-0.6%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +135.4% | -5.3% | -6.8% | -11.0% | -7.0% | -14.9% | -15.4% | +61.5% | -11.0% | -13.8% | +26.5% | |
| – | +136.1% | -5.3% | -6.8% | -11.1% | -7.3% | -14.9% | -15.4% | +62.0% | -11.3% | -13.9% | +26.9% | |
| – | +147.1% | -5.9% | -6.7% | -11.2% | -8.0% | -15.8% | -15.6% | +65.0% | -11.4% | -15.3% | +28.9% | |
| – | – | – | -6.7% | -11.2% | – | – | -15.6% | +65.0% | – | – | +28.9% | |
| – | – | – | +91.2% | +69.5% | – | – | -1.7% | +13.1% | – | – | +5.9% | |
| – | – | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -9.7% | +25.8% | +3.5% | -14.1% | +44.1% | -3.8% | +12.1% | +4.6% | +13.2% | -22.3% | +18.8% | |
| – | -9.4% | +25.7% | +3.7% | -14.0% | +40.3% | -3.5% | +12.7% | +4.9% | +12.9% | -22.6% | +19.4% | |
| – | – | – | -19.8% | +2.9% | – | – | -17.0% | -14.8% | – | – | -6.7% | |
| – | -19.3% | +91.0% | -46.6% | +41.3% | +8.7% | -7.4% | +15.0% | -47.6% | +100.7% | -47.0% | +3.1% | |
| – | +150.8% | -6.5% | -7.4% | -10.8% | -9.8% | -15.8% | -18.2% | +69.4% | -13.1% | -12.9% | +27.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +27.8% | +2.9% | +0.2% | +0.2% | +0.6% | +0.3% | +0.3% | +13.8% | +4.7% | +0.1% | +4.2% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.